Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer

RT @JournalofExper1: New study! 👇 📍𝐀𝐜𝐭𝐢𝐧-𝐥𝐢𝐤𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝟔𝐀/𝐌𝐘𝐂/𝐂𝐃𝐊𝟐 𝐚𝐱𝐢𝐬 𝐜𝐨𝐧𝐟𝐞𝐫𝐬 high proliferative 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 𝐢𝐧 𝐭𝐫𝐢𝐩𝐥𝐞-𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞…

New study! 👇 📍𝐀𝐜𝐭𝐢𝐧-𝐥𝐢𝐤𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝟔𝐀/𝐌𝐘𝐂/𝐂𝐃𝐊𝟐 𝐚𝐱𝐢𝐬 𝐜𝐨𝐧𝐟𝐞𝐫𝐬 high proliferative 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 𝐢𝐧 𝐭𝐫𝐢𝐩𝐥𝐞-𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 💻 https://t.co/IhjdE1p3gt #TripleNegativeBreastCancer #MYC @IREISGufficiale https://t.co/7To1OG1Lkt

ACTL6A prolongs the retention of MYC in triple negative breast cancer and suggest that pharmacological targeting ACTL6A/MYC/CDK2 axis might have therapeutic potential in patients. https://t.co/NEC3mYhVsR